Stay updated on GLPG1690 in IPF: ISABELA2 Clinical Trial
Sign up to get notified when there's something new on the GLPG1690 in IPF: ISABELA2 Clinical Trial page.

Latest updates to the GLPG1690 in IPF: ISABELA2 Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded a note that PubMed publications are automatically filled from PubMed, and updated the revision marker to v3.3.2. The deletions now describe PubMed publications as automatically created and reference revision v3.2.0.SummaryDifference0.0%

- Check18 days agoChange DetectedThe funding status notice about lapse in government funding and operating status updates has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check40 days agoChange DetectedNo substantive content changes were observed; the updates seem limited to layout or UI adjustments, with the core study details and approvals unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference1%

- Check69 days agoChange DetectedAdds Revision: v3.1.0 and removes several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and Revision: v3.0.2; overall, updates versioning and trims older topics.SummaryDifference0.2%

- Check83 days agoChange DetectedChange from v3.0.1 to v3.0.2 indicates a minor version upgrade. A 'Back to Top' link was removed, with no other substantive content changes.SummaryDifference0.1%

Stay in the know with updates to GLPG1690 in IPF: ISABELA2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GLPG1690 in IPF: ISABELA2 Clinical Trial page.